Log in

TCRG Cannaisseur Group Inc. OTC · United States

Cannaisseur Group (TCRG) news

Cannaisseur Group Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker TCRG, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Cannaisseur Group news

We have not published a story on Cannaisseur Group yet. When there is news, it will appear here.

Cannaisseur Group annual financials

LineFY2025FY2024
Revenue$0$700
Net income (loss)-$1.8 million-$1.3 million
Cash from operations-$127,451-$110,627
Cash and equivalents$22$563

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $41.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Cannaisseur Group

What is the ticker symbol of Cannaisseur Group?

Cannaisseur Group Inc. trades under the ticker TCRG on OTC.

Where is Cannaisseur Group listed?

Cannaisseur Group Inc. is listed on OTC.

Which country or territory is Cannaisseur Group listed under?

Our directory records Cannaisseur Group Inc. under United States.

Does aibio.space cover Cannaisseur Group?

aibio.space lists Cannaisseur Group Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was Cannaisseur Group's revenue last year?

$0 for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Cannaisseur Group profitable?

Cannaisseur Group Inc. reported a net loss of $1.8 million for the fiscal year ended Dec 31, 2025, and used $127,451 of cash in operations, per its annual report to the SEC.

How much cash does Cannaisseur Group have?

$41 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: Cannaisseur Group

Members talk about Cannaisseur Group (TCRG). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:TCRG on TradingView.

Listing details

Cannaisseur Group Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker TCRG, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Cannaisseur Group Inc.
Ticker
TCRG
Listing
OTC
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.